Global Hemoglobin Testing Market 2016-2020

The red blood cells in the bloodstream carry a protein known as hemoglobin, which helps to transport oxygen throughout the body. Hemoglobin tests are conducted to detect the quantity of hemoglobin present in the blood. These tests are often done as a part of complete blood count during a routine health check-up or at the time of any illness to determine the type of anemia, which occurs due to low count of red blood cells.

Studies estimated that worldwide around 416 million people were living with diabetes in 2015. Out of which, around 46% of them, i.e., 191.3 million people, were not diagnosed with this disease, owing to lack of awareness. Diabetes and anemia are not directly linked, but studies reveal that around 26% of people with diabetes are diagnosed with anemia. Kidney damage or chronic kidney disease is a common condition observed in people with chronic diabetes.

The analysts forecast global hemoglobin testing market to grow at a CAGR of 10.58% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global hemoglobin testing market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of hemoglobin testing equipment and consumables.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

The report, Global Hemoglobin Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• Abbott Diagnostics
• Alere
• Danaher
• EKF Diagnostics Holdings
• Roche Diagnostics

Other prominent vendors

• ACON Laboratories
• ARKRAY
• Bayer Medical Care
• Bio-Rad Laboratories
• Daiichi Biotech
• DiaSys Diagnostic Systems
• Diazyme Laboratories
• Epinex Diagnostics
• Erba Diagnostics
• Fisher Scientific
• GREEN CROSS MEDIS
• HORIBA
• HUMAN Gesellschaft für Biochemica und Diagnostica
• Masimo
• Mindray Medical International
• OrSense
• PTS Diagnostics
• Randox Laboratories
• Sebia
• Siemens Healthcare
• Sysmex
• TaiDoc Technology
• Tosoh Bioscience
• Trinity Biotech
• Una Health

Market driver

• Development and launch of novel hemoglobin testing devices
• For a full, detailed list, view our report

Market challenge

• High cost and maintenance of hemoglobin testing
• For a full, detailed list, view our report

Market trend

• Direct-to-consumer testing
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights
Invasive method
Non-invasive method

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by product
Global hemoglobin testing equipment market
Global hemoglobin testing reagents and consumables market

PART 07: Market segmentation by technology
Chromatography
Immunoassay
Other

PART 08: Market segmentation by end-user
Laboratories
Hospitals
Research centers

PART 09: Geographical segmentation
Hemoglobin testing market in Americas
Reimbursement by Medicare in US
Hemoglobin testing market in EMEA
Hemoglobin testing market in APAC

PART 10: Market drivers
Increasing incidence of diabetes and popularity of HbA1c tests
Favorable reimbursement of hemoglobin testing
Development and launch of novel hemoglobin testing devices

PART 11: Impact of drivers

PART 12: Market challenges
High cost and maintenance of hemoglobin testing
Stringent regulatory issues
Threat of substitute products

PART 13: Impact of drivers and challenges

PART 14: Market trends
Shift from centralized laboratory to POCT
Increased mergers and acquisition (M&A)
Direct-to-consumer testing

PART 15: Vendor landscape
Competitive scenario

PART 16: Key vendor profiles
Abbott Diagnostics
Alere
Danaher
EKF Diagnostics Holdings
Roche Diagnostics
Other prominent vendors

PART 17: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Types of hemoglobin testing methods
Exhibit 03: Global hemoglobin testing market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global hemoglobin testing market segmentation based on product
Exhibit 06: Global hemoglobin testing market segmentation based on product 2015
Exhibit 07: Global hemoglobin testing market segmentation based on product 2020
Exhibit 08: Global hemoglobin testing equipment market 2015
Exhibit 09: Global hemoglobin testing equipment market 2020
Exhibit 10: Global hemoglobin testing equipment market 2015-2020 ($ millions)
Exhibit 11: Global laboratory testing market 2015-2020 ($ millions)
Exhibit 12: Global POCT equipment market 2015-2020 ($ millions)
Exhibit 13: Global hemoglobin testing reagent and consumables market 2015-2020 ($ billions)
Exhibit 14: Segmentation of global hemoglobin testing market by product
Exhibit 15: Segmentation of global hemoglobin testing market by product ($ millions)
Exhibit 16: Segmentation of global hemoglobin testing market by technology 2015
Exhibit 17: Segmentation of global hemoglobin testing market by end-user 2015
Exhibit 18: Segmentation of global hemoglobin testing market by geography 2015
Exhibit 19: Segmentation of global hemoglobin testing market by geography 2020
Exhibit 20: Hemoglobinin testing market in Americas 2015-2020 ($ millions)
Exhibit 21: Selected laboratory service with national limitation amount (NLA) provided by Medicare
Exhibit 22: Estimation of few diseases in US
Exhibit 23: Hemoglobin testing market in EMEA 2015-2020 ($ millions)
Exhibit 24: Hemoglobin testing market in APAC 2015-2020 ($ millions)
Exhibit 25: Segmentation of global hemoglobin testing market by geography
Exhibit 26: Segmentation of global hemoglobin testing market by geography ($ millions)
Exhibit 27: Impact of drivers
Exhibit 28: Impact of drivers and challenges
Exhibit 29: Abbott Diagnostics: Key takeaways
Exhibit 30: Alere: Business segmentation by revenue 2014
Exhibit 31: Alere: Cardiometabolic division revenue and YoY growth rate 2012-2014 ($ millions)
Exhibit 32: Alere: Key takeaways
Exhibit 33: Danaher: Key takeaways
Exhibit 34: EKF Diagnostics: Business segmentation by revenue 2014
Exhibit 35: EKF Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 36: EKF Diagnostics Holdings: Key takeaways
Exhibit 37: Roche Diagnostics: Business segmentation by revenue 2015
Exhibit 38: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2015
Exhibit 39: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 40: Roche Diagnostics: Diabetes care - YoY revenue and growth rate ($ billions)
Exhibit 41: Roche Diagnostics: Key takeaways